These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

573 related articles for article (PubMed ID: 32809300)

  • 41. Polydatin, a potential NOX5 agonist, synergistically enhances antitumor activity of cisplatin by stimulating oxidative stress in non‑small cell lung cancer.
    Wu S; Zhao Q; Liu S; Kuang J; Zhang J; Onga A; Shen Y; Wang J; Sui H; Ni L; Ye Y; Tu X; Le HB; Zheng Y; Cui R; Zhu W
    Int J Oncol; 2024 Aug; 65(2):. PubMed ID: 38873997
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon Consensus Sequence-Binding Protein 8, a Tumor Suppressor, Suppresses Tumor Growth and Invasion of Non-Small Cell Lung Cancer by Interacting with the Wnt/β-Catenin Pathway.
    Ye L; Xiang T; Zhu J; Li D; Shao Q; Peng W; Tang J; Li L; Ren G
    Cell Physiol Biochem; 2018; 51(2):961-978. PubMed ID: 30466106
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Olean-28,13b-olide 2 plays a role in cisplatin-mediated apoptosis and reverses cisplatin resistance in human lung cancer through multiple signaling pathways.
    Zhu B; Ren C; Du K; Zhu H; Ai Y; Kang F; Luo Y; Liu W; Wang L; Xu Y; Jiang X; Zhang Y
    Biochem Pharmacol; 2019 Dec; 170():113642. PubMed ID: 31541631
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hypoxia-inducible factor 1α (HIF-1α) and reactive oxygen species (ROS) mediates radiation-induced invasiveness through the SDF-1α/CXCR4 pathway in non-small cell lung carcinoma cells.
    Gu Q; He Y; Ji J; Yao Y; Shen W; Luo J; Zhu W; Cao H; Geng Y; Xu J; Zhang S; Cao J; Ding WQ
    Oncotarget; 2015 May; 6(13):10893-907. PubMed ID: 25843954
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Acetyl-11-keto-β-boswellic acid enhances the cisplatin sensitivity of non-small cell lung cancer cells through cell cycle arrest, apoptosis induction, and autophagy suppression via p21-dependent signaling pathway.
    Lv M; Zhuang X; Zhang Q; Cheng Y; Wu D; Wang X; Qiao T
    Cell Biol Toxicol; 2021 Apr; 37(2):209-228. PubMed ID: 32562082
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silence of fibronectin 1 increases cisplatin sensitivity of non-small cell lung cancer cell line.
    Gao W; Liu Y; Qin R; Liu D; Feng Q
    Biochem Biophys Res Commun; 2016 Jul; 476(1):35-41. PubMed ID: 27207836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hypoxia-Induced Autophagy Enhances Cisplatin Resistance in Human Bladder Cancer Cells by Targeting Hypoxia-Inducible Factor-1
    Mao X; Nanzhang ; Xiao J; Wu H; Ding K
    J Immunol Res; 2021; 2021():8887437. PubMed ID: 33681390
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIF-1α-induced autophagy contributes to cisplatin resistance in ovarian cancer cells.
    Long F; Liu W; Jia P; Wang H; Jiang G; Wang T
    Pharmazie; 2018 Sep; 73(9):533-536. PubMed ID: 30223937
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cyclophilin a represses reactive oxygen species generation and death of hypoxic non-small-cell lung cancer cells by degrading thioredoxin-interacting protein.
    Li Y; Yang L
    Cell Cycle; 2022 Sep; 21(18):1996-2007. PubMed ID: 35579671
    [TBL] [Abstract][Full Text] [Related]  

  • 50. GOLPH3 inhibition overcomes cisplatin resistance by restoring the glutathione/reactive oxygen species balance in the A549 non‑small cell lung cancer cell line.
    Wei Q; Lin J; Lin Z; Yu N; Wu Y; Tan X; Xue D
    Oncol Rep; 2024 Dec; 52(6):. PubMed ID: 39422070
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of the JAK/STAT pathway with ruxolitinib overcomes cisplatin resistance in non-small-cell lung cancer NSCLC.
    Hu Y; Hong Y; Xu Y; Liu P; Guo DH; Chen Y
    Apoptosis; 2014 Nov; 19(11):1627-36. PubMed ID: 25213670
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.
    Baghbani E; Noorolyai S; Rahmani S; Shanehbandi D; Shadbad MA; Aghebati-Maleki L; Mokhtarzadeh A; Brunetti O; Fasano R; Silvestris N; Baradaran B
    Biomed Pharmacother; 2022 Jan; 145():112370. PubMed ID: 34862113
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Mannose shows antitumour properties against lung cancer via inhibiting proliferation, promoting cisplatin‑mediated apoptosis and reducing metastasis.
    Wang Y; Xie S; He B
    Mol Med Rep; 2020 Oct; 22(4):2957-2965. PubMed ID: 32700756
    [TBL] [Abstract][Full Text] [Related]  

  • 54. XQ2, a novel TPZ derivative, induced G2/M phase arrest and apoptosis under hypoxia in non-small cell lung cancer cells.
    Lou J; Zhou X; Weng Q; Wang DD; Xia Q; Hu Y; He Q; Yang B; Luo P
    Biosci Biotechnol Biochem; 2010; 74(6):1181-7. PubMed ID: 20530905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS/p38 and ROS/ERK signalling.
    Hao Y; Huang Y; Chen J; Li J; Yuan Y; Wang M; Han L; Xin X; Wang H; Lin D; Peng F; Yu F; Zheng C; Shen C
    Cell Prolif; 2020 Aug; 53(8):e12869. PubMed ID: 32597573
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Nucleic acid binding properties of allicin: spectroscopic analysis and estimation of anti-tumor potential.
    Tyagi G; Pradhan S; Srivastava T; Mehrotra R
    Biochim Biophys Acta; 2014 Jan; 1840(1):350-6. PubMed ID: 24041991
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cisplatin resistance in non-small cell lung cancer cells is associated with an abrogation of cisplatin-induced G2/M cell cycle arrest.
    Sarin N; Engel F; Kalayda GV; Mannewitz M; Cinatl J; Rothweiler F; Michaelis M; Saafan H; Ritter CA; Jaehde U; Frötschl R
    PLoS One; 2017; 12(7):e0181081. PubMed ID: 28746345
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 7-O-geranylquercetin-induced autophagy contributes to apoptosis via ROS generation in human non-small cell lung cancer cells.
    Wang EX; Zou BY; Shi L; Du LY; Zhu YY; Jiang YM; Ma XD; Kang XH; Wang CY; Zhen YH; Sun LD
    Life Sci; 2017 Jul; 180():102-113. PubMed ID: 28495516
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Metformin enhances cisplatin cytotoxicity by suppressing signal transducer and activator of transcription-3 activity independently of the liver kinase B1-AMP-activated protein kinase pathway.
    Lin CC; Yeh HH; Huang WL; Yan JJ; Lai WW; Su WP; Chen HH; Su WC
    Am J Respir Cell Mol Biol; 2013 Aug; 49(2):241-50. PubMed ID: 23526220
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Long noncoding RNA HOTAIR, a hypoxia-inducible factor-1α activated driver of malignancy, enhances hypoxic cancer cell proliferation, migration, and invasion in non-small cell lung cancer.
    Zhou C; Ye L; Jiang C; Bai J; Chi Y; Zhang H
    Tumour Biol; 2015 Dec; 36(12):9179-88. PubMed ID: 26088446
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 29.